Related Experiment Video

Updated: May 28, 2025

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

10.7K

Life-threatening massive hemoptysis due to pulmonary arteriovenous malformation: An uncommon case

Nguyen Lan Hieu1, Le Hoan2, Nguyen Ngoc Cuong3

  • 1Cardiovascular Center, Hanoi Medical University Hospital, Hanoi Medical University, Ton That Tung Street, Hanoi 10000, Viet Nam.

Radiology Case Reports
|February 13, 2025
PubMed

We present the case of a 42-year-old woman with no past medical history who was admitted to the emergency department because of massive hemoptysis estimated to be greater than 250ml of fresh blood. Physical examination revealed that her vital signs were initially fluctuating on admission with decreased arterial oxygen saturation, tachypnea, mildly elevated blood pressure and heart rate, and no fever. The head and neck exams were notable for the presence of blood in the oropharynx. No active bleeding site was found during nasopharyngoscopy. Chest X-ray shows a well-defined homogeneous mass-like opacity with lobulated shapes of the right lung. Contrast-enhanced computed tomography demonstrates a single 1.2 × 1 cm pulmonary arteriovenous malformation (PAVM) in the right upper lobe fed by an anterior segment pulmonary artery measuring 3.5mm in diameter. The final diagnosis was concluded as massive hemoptysis due to right pulmonary arteriovenous malformation. In this report, we present a rare clinical case with a silent developmental PAVM that did not cause symptoms until massive hemoptysis which can be life-threatening.

Keywords:
Chest x-rayComputed tomographyContrast-enhancedEmbolizationHemoptysisPulmonary arteriovenous malformation

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.6K
Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model08:51

Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model

Published on: November 11, 2022

1.4K

Related Concept Videos

Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
168
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
147
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
117
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
166
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
159